Integrating clinical outcomes with molecular simulations to guide the selection of non-classical EGFR-TKIs: A comprehensive analysis and development of treatment strategies.

Vizimpro (dacomitinib) - Pfizer

Gilotrif (afatinib) - Boehringer Ingelheim

http://www.ncbi.nlm.nih.gov/pubmed/42719457

Chang Li; Fang Wei; Ge Gao; Nan Li; Niu Niu; Yan Wang

Sep 11, 2026